Day 2 at the 2017 annual meeting of the American Society of Clinical Oncology further highlighted immunotherapy's potential to treat many of the most common types of cancer. Here is an overview of the data coming out of today's session:
Multiple Tumor Types:
Stomach & Gastrointestinal Cancer:
Come back for more updates from tomorrow's presentations.
June is Cancer Immunotherapy Month
Read Previous Article
ASCO17: Day 2 Immunotherapy Highlights
Read Next Article
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
Cancer is not “one-size-fits-all” and neither are its treatments, especially when it comes to immunotherapy. Learn how CRI is helping more people overcome cancer.
Immunotherapy updates from the world's largest cancer conference, the Annual Meeting of the American Society for Clinical Oncology (ASCO).